Table 2.
Authors [Ref.] | Patients, n | Mean follow-up, years |
Good/excellent results, s% |
---|---|---|---|
Asch et al. [2] | 212 | 2 | 80 |
Atlas et al.[3] | 217 | 10 | 69 |
Bakhsh [4] | 39 | 10 | 79 |
Butterman [5] | 100 | 2.5 | 92 |
Casal-Moro et al. [6] | 120 | 5 | 95 |
Chang et al. [8] | 26 | 3 | Not given |
Cooper and Feuer [10] | 100 | 2 | 94 |
Davis [11] | 984 | 10.8 | 89 |
Dewing et al. [12] | 183 | 2.1 | 85 |
Dvorak [14] | 371 | 10.5 | 72 |
Ebeling et al. [15] | 485 | 2 | 73 |
Findlay et al. [16] | 79 | 10 | 83 |
Gurdjian et al. [18] | 623 | 9 | 74 |
Hsu et al. [20] | 226 | 2 | 82 |
Jansson et al. [21] | 22,261 | 6 | 78 |
Jensdottir et al. [22] | 134 | 20.7 | 91 |
Kotilainen et al. [23] | 237 | 2 | 92 |
Lewis et al. [26] | 83 | 7.5 | 89 |
Liu et al. [27] | 82 | 6.4 | 84 |
Loupasis et al. [28] | 109 | 12.7 | 64 |
Mariconda et al. [29] | 201 | 27.8 | 90 |
Marin [30] | 600 | 10 | 83 |
Martinez Quinones et al. [32] | 142 | 5 | 93 |
Moore et al. [34] | 100 | 8.6 | 93 |
Naylor [35] | 204 | 17.5 | 79 |
Nykvist et al. [36] | 197 | 12.9 | 81 |
Österman et al. [37] | 28 | 2 | 93 |
Padua et al. [38] | 120 | 12.1 | 77 |
Papavero and Caspar [39] | 200 | Not given | 79 |
Pappas et al. [40] | 654 | 1.5 | 96 |
Parker et al. [41] | 111 | 3.1 | 68 |
Peul et al. [42] | 125 | 2 | 81 |
Salenius and Laurent [43] | 695 | 6 | 63 |
Schoeggl et al. [44] | 672 | 6.3 | 77 |
Schramm et al. [45] | 3,238 | 4 | 80 |
Silverplats et al. [46] | 140 | 7.3 | 70 |
Spangfort [47] | 2,503 | Not given | 77 |
Tregonning et al. [48] | 91 | 9.7 | 63 |
Vik et al. [49] | 124 | 8.5 | 81 |
Weber [50] | 56 | 4 | 86 |
Weinstein et al. [51] | 245 | 4 | 84 |
Williams [52] | 530 | 3 | 91 |
Woertgen et al. [53] | 98 | 2.3 | 66 |
Wu et al. [54] | 1,231 | 2.3 | 77 |
Yorimitsu et al. [56] | 72 | 14.3 | 87 |
Total | 39,048 | ||
Mean | 6.1 | 78.9 |